| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil serves as a Chief Executive Officer at BBIO. Across recent SEC filings that breaks down to 0 buys and 216 sells. Those positions are worth an estimated $34.3M at current prices.
Historically, Kumar Neil's trades have earned a below-average insider score of 31/100 across 40 rated trades. Over a 12-month horizon, 9.1% of those trades were profitable, with an average 12-month return of -85.0%.
The biggest single holding is BBIO (~$34.3M) as Chief Executive Officer. The recent filings there lean toward selling, a net 4,118,030 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 10,000 | $69.08 | $690,847.12 | -2.0% | - | - | |
| Aug 19, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 44,980 | $82.86 | $3,727,250.87 | -5.7% | - | - | |
| Jun 5, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $67.67 | $5,413,288.78 | -1.6% | +11.5% | - | |
| May 21, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 26,103 | $69.44 | $1,812,521.76 | -9.7% | +19.5% | - | |
| May 8, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $67.40 | $5,392,243.41 | -1.6% | +22.9% | - | |
| Apr 10, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $74.61 | $5,968,780.10 | -1.8% | +20.9% | - | |
| Mar 13, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $68.76 | $5,501,045.44 | -1.5% | -2.7% | - | |
| Feb 19, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 28,053 | $71.39 | $2,002,717.48 | -10.7% | -3.5% | - | |
| Feb 11, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $71.86 | $5,748,666.24 | -1.5% | -10.1% | - | |
| Jan 9, 2026 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $75.54 | $6,043,168.23 | -1.7% | -2.2% | - |